Zydus Lifesciences Ltd has completed its planned equity investment in Torrent Urja 25 Private Limited, the company informed stock exchanges on May 20, 2026.
The pharmaceutical major said the transaction was executed through the company and its subsidiaries under a previously signed Share Subscription and Shareholders’ Agreement (SSSAs). With the latest tranche allotment, Zydus and its subsidiaries now hold 22.06% of Torrent Urja 25’s paid-up share capital.
As part of the final phase of the transaction, Zydus invested ₹9.01 crore on May 19, 2026, towards subscription of 90,17,848 equity shares under Tranches 2, 3 and 4.
The company had earlier invested ₹3.86 crore under Tranche 1 for subscription of 38,64,792 equity shares, details of which were disclosed in earlier filings dated May 28, 2025 and June 27, 2025.
Following the latest investment, the company confirmed that the entire share subscription transaction has now been completed.
The development comes at a time when several large Indian corporates, including pharmaceutical companies, are increasing investments in renewable and energy-related ventures to improve sustainability initiatives and optimise long-term operational costs.
Shares of Zydus Lifesciences have remained in focus recently after the company reported strong Q4FY26 earnings and announced a ₹1,100 crore share buyback earlier this week.
Disclaimer: This article is for informational purposes only and should not be construed as investment advice.